Biomedical Photoacoustic Imaging and Sensing Using Affordable Resources

Singh, Mithun Kuniyil Ajith; Xia, Wenfeng

doi:10.3390/s21072572

Cited by 4 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The PA effect was first reported by Bell in 1880 and began to be applied in the field of material testing in the 1970s. 58 With the further development of ultrasonic detection technology and data acquisition system and computing power, PA technology was gradually applied in the biomedical field. 59 For example, Lee et al 60 prepared H 2 O 2 -triggered thrombus-targeted therapeutic (T-FBM) NPs via conjugating borylbenzyl carbonate and fluorescent IR780 to maltodextrin.…”

Section: Us-based Biomedical Applicationmentioning

confidence: 99%

Ultrasound nanomedicine and materdicine

Wang

Chang

et al. 2023

J. Mater. Chem. B

View full text Add to dashboard Cite

show abstract

Section: Us-based Biomedical Applicationmentioning

confidence: 99%

Ultrasound nanomedicine and materdicine

Wang

Chang

et al. 2023

J. Mater. Chem. B

View full text Add to dashboard Cite

show abstract

“…Photoacoustic (PA) imaging is a biomedical imaging modality upon the laser‐generated ultrasound, which integrates the optical and ultrasonic technologies. [ 29 ] Although the photoacoustic effect was early reported at 1880s, [ 30 ] the employment of PA imaging in biomedical field had not been developed until the past two decades.…”

Section: Quantitative Photoacoustic Nanoprobementioning

confidence: 99%

Molecular imaging of tumour‐associated pathological biomarkers with smart nanoprobe: From “Seeing” to “Measuring”

Zhang,

Li,

Liu

et al. 2023

Exploration

View full text Add to dashboard Cite

Although the extraordinary progress has been made in molecular biology, the prevention of cancer remains arduous. Most solid tumours exhibit both spatial and temporal heterogeneity, which is difficult to be mimicked in vitro. Additionally, the complex biochemical and immune features of tumour microenvironment significantly affect the tumour development. Molecular imaging aims at the exploitation of tumour‐associated molecules as specific targets of customized molecular probe, thereby generating image contrast of tumour markers, and offering opportunities to non‐invasively evaluate the pathological characteristics of tumours in vivo. Particularly, there are no “standard markers” as control in clinical imaging diagnosis of individuals, so the tumour pathological characteristics‐responsive nanoprobe‐based quantitative molecular imaging, which is able to visualize and determine the accurate content values of heterogeneous distribution of pathological molecules in solid tumours, can provide criteria for cancer diagnosis. In this context, a variety of “smart” quantitative molecular imaging nanoprobes have been designed, in order to provide feasible approaches to quantitatively visualize the tumour‐associated pathological molecules in vivo. This review summarizes the recent achievements in the designs of these nanoprobes, and highlights the state‐of‐the‐art technologies in quantitative imaging of tumour‐associated pathological molecules.

show abstract